Bio-Techne
TECH
72.67
-0.03
-0.04%
Bio-Techne
US · TECH
#1365 by market cap
Listed 1970
72.67
-0.03
-0.04%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:01
Quant vs Street three independent views, side by side
StockVane factor grade
B
Momentum strategy signal
Hold
Analyst consensus
Sell
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Deteriorating
7
■ Upgrades■ Downgrades
- 0 upgrades vs 7 downgrades among tracked analyst rating changes.
- Most recent: Argus Research moved from Buy to Sell on 2026-10-26.
Analyst consensus 2 analysts
Sell
Avg price target 73.00 +0.5%
Price target rangecurrent 72.67
Low73.00
Avg73.00
High73.00
Buy 0%
Hold 50%
Sell 50%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-09 | RBC Capital | -- | Hold | 73.00 |
| 2026-10-26 | Argus Research | -- | Sell | -- |
| 2026-08-12 | William Blair | -- | Hold | -- |
| 2026-08-12 | RBC Capital | -- | Hold | 73.00 |
| 2026-07-08 | RBC Capital | -- | Hold | 73.00 |
| 2026-06-30 | TD Cowen | -- | Hold | 73.00 |
| 2026-06-30 | StoneX | -- | Hold | -- |
| 2026-06-29 | Citi | -- | Hold | 73.00 |
| 2026-06-27 | William Blair | -- | Hold | -- |
| 2026-06-26 | TD Cowen | -- | Hold | 73.00 |
| 2026-06-26 | William Blair | -- | Hold | -- |
| 2026-06-26 | Baird | -- | Hold | 73.00 |
| 2026-06-26 | Deutsche Bank | -- | Hold | 73.00 |
| 2026-06-26 | Stephens | -- | Hold | 73.00 |
| 2026-06-26 | Citi | -- | Hold | 73.00 |
| 2026-06-25 | William Blair | -- | Hold | -- |
| 2026-06-25 | Leerink Partners | -- | Hold | 73.00 |
| 2026-06-23 | TD Cowen | -- | Buy | 65.00 |
| 2026-06-11 | TD Cowen | -- | Buy | 65.00 |
| 2026-06-11 | Piper Sandler | -- | Hold | 65.00 |
| 2026-05-28 | Citi | -- | Buy | 70.00 |
| 2026-05-14 | RBC Capital | -- | Buy | 62.00 |
| 2026-05-08 | Deutsche Bank | -- | Buy | 66.00 |
| 2026-05-07 | Wells Fargo | -- | Buy | 62.00 |
| 2026-05-07 | William Blair | -- | Buy | -- |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-10-26 | Argus Research | Buy → Sell | -- |
| 2026-07-08 | RBC Capital | Buy → Hold | 73.00 |
| 2026-06-26 | Deutsche Bank | Buy → Hold | 73.00 |
| 2026-06-26 | Citi | Buy → Hold | 73.00 |
| 2026-06-26 | TD Cowen | Buy → Hold | 73.00 |
| 2026-06-25 | William Blair | Buy → Hold | -- |
| 2026-01-05 | Evercore | Buy → Hold | 62.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-05-06 | After close | ±7.59% | +7.39% (in line) |
| 2026/Q2 | 2026-02-04 | -- | ±9.12% | +6.25% (in line) |
| 2026/Q1 | 2025-11-05 | -- | ±11.57% | -1.90% (in line) |
| 2025/Q4 | 2025-08-06 | -- | ±11.80% | -8.73% (in line) |
| 2025/Q3 | 2025-05-07 | -- | ±10.68% | +2.16% (in line) |
| 2025/Q2 | 2025-02-05 | -- | ±8.17% | +3.72% (in line) |
| 2025/Q1 | 2024-10-30 | -- | ±10.89% | +7.46% (in line) |
| 2024/Q4 | 2024-08-07 | -- | ±9.38% | -9.51% (beat) |
| 2024/Q3 | 2024-05-01 | -- | ±11.45% | +16.22% (beat) |
| 2024/Q2 | 2024-02-01 | -- | ±7.11% | -2.53% (in line) |
| 2024/Q1 | 2023-10-31 | -- | ±6.97% | -3.55% (in line) |
| 2023/Q4 | 2023-08-08 | -- | ±10.04% | +3.70% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 20:01:25 · For reference only, not investment advice and not tailored to your situation.
Bio-Techne discussion 0 comments